Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eye diseases
Biotech
Lilly bags eye-catching gene therapy in $475M deal
The Indiana drugmaker will gain rights to a gene therapy that has restored vision in 11 children born legally blind.
Darren Incorvaia
Nov 10, 2025 7:00am
Fatty acid eye injections restore vision in old mice
Sep 26, 2025 2:10pm
Alcon to buy LumiThera’s light-based therapy for dry AMD
Jul 8, 2025 10:30am
Opthea scraps wet AMD program after eye drug loses to Lucentis
Mar 31, 2025 6:55am
NIH creates eye drops that protect mice from vision loss
Mar 25, 2025 3:10pm
Eye disease biotech looks to clinical trials with $93M series B
Mar 25, 2025 8:00am
